TRT & Immune Function: A Balancing Act

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Testosterone acts as a modulator of the immune system, with both immunosuppressive and immune-enhancing effects. TRT can normalize immune responses in hypogonadal men, but requires careful consideration of overall immune status.

TRT and Immune Function: A Balancing Act

The relationship between Testosterone Replacement Therapy (TRT) and immune function is a nuanced area, with testosterone acting as a significant modulator of the immune system. While often perceived as an immunosuppressant, its role is more complex, influencing both innate and adaptive immunity.

Testosterone is known to have immunosuppressive properties, which can explain why men generally exhibit a higher susceptibility to certain infections and a lower incidence of autoimmune diseases compared to women. This is not a simple suppression, however. Research indicates that testosterone can down-regulate pro-inflammatory responses, as shown by Trumble et al. (2016), who found higher endogenous testosterone associated with down-regulated cytokine responses.

Conversely, low testosterone levels have been linked to impaired immune responses. Hypogonadal men may experience a weakened immune system, making them more vulnerable to infections. Optimizing testosterone levels through TRT can, in some cases, restore a more robust immune response, particularly in individuals whose immune function was compromised due to severe deficiency.

The impact of TRT on the immune system is not always straightforward. For instance, while testosterone may reduce certain inflammatory markers, it can also potentiate monocyte responses, leading to increased production of cytokines like TNF-alpha, IL-6, and IL-15, as observed in studies on gender-affirming testosterone treatment (Lakshmikanth et al., 2024). This suggests a differential effect on various immune cell types and pathways.

Unlike the direct stimulatory effect of testosterone on muscle protein synthesis, its influence on immunity is more regulatory. It acts as a 'brake pedal' on certain immune responses, preventing over-activation, but can also prime other components. For example, while corticosteroids are broad-spectrum immunosuppressants, testosterone's effects are more targeted and context-dependent, often aiming for immune homeostasis rather than outright suppression.

The clinical implications are significant. In men with chronic inflammatory conditions or autoimmune diseases, TRT might offer some anti-inflammatory benefits. However, in situations requiring a strong immune response, such as vaccination or acute infection, the immunosuppressive aspects of testosterone could theoretically be a concern. This is why careful consideration of a patient's overall health and immune status is crucial before initiating TRT.

In clinical practice, we don't typically initiate TRT solely for immune modulation, but we are mindful of its effects. A patient with persistently low testosterone and recurrent minor infections might find that optimizing his levels leads to a general improvement in his resilience to illness. However, if a patient is undergoing chemotherapy or has a severe immunodeficiency, the potential impact of TRT on their immune system would warrant a much more cautious approach and close monitoring.

The practical takeaway is that testosterone plays a vital, albeit complex, role in immune function. While TRT can help normalize immune responses in hypogonadal men, it's not an immune booster in the conventional sense. If you are considering TRT, discuss your immune health, any history of infections, or autoimmune conditions with your physician. This will allow for a personalized approach that balances the benefits of TRT with its potential immune modulating effects, ensuring your overall health is prioritized.